Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
7.45
-0.05 (-0.67%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Solid Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 733 | 439 | 160 | 124 | 105 | 193 | |
| Market Cap Growth | 250.40% | 174.95% | 29.00% | 17.92% | -45.57% | -61.33% | |
| Enterprise Value | 566 | 225 | 13 | 8 | -11 | -34 | |
| Last Close Price | 7.45 | 5.64 | 4.00 | 6.14 | 5.38 | 26.25 | |
| PS Ratio | - | - | - | - | 12.98 | 14.17 | |
| PB Ratio | 3.27 | 2.44 | 1.16 | 0.98 | 0.50 | 0.93 | |
| P/TBV Ratio | 4.07 | 2.44 | 1.16 | 0.98 | 0.50 | 0.93 | |
| Debt / Equity Ratio | 0.12 | 0.12 | 0.18 | 0.21 | 0.14 | 0.01 | |
| Net Debt / Equity Ratio | -0.93 | -0.93 | -0.91 | -0.77 | -0.87 | -0.99 | |
| Net Debt / EBITDA Ratio | 0.94 | 0.94 | 0.98 | 0.96 | 2.01 | 2.97 | |
| Net Debt / FCF Ratio | 1.06 | 1.06 | 1.24 | 1.02 | 1.83 | 2.60 | |
| Asset Turnover | - | - | - | - | 0.03 | 0.07 | |
| Quick Ratio | 5.61 | 5.61 | 4.92 | 8.52 | 9.49 | 8.81 | |
| Current Ratio | 6.14 | 6.14 | 5.20 | 8.94 | 9.76 | 9.43 | |
| Return on Equity (ROE) | -109.90% | -109.90% | -94.56% | -56.79% | -40.96% | -42.43% | |
| Return on Assets (ROA) | -53.18% | -53.18% | -45.86% | -30.67% | -23.95% | -22.38% | |
| Return on Capital Employed (ROCE) | -90.00% | -90.00% | -81.90% | -69.30% | -39.70% | -34.60% | |
| Earnings Yield | -23.78% | -39.67% | -78.02% | -77.50% | -81.84% | -37.40% | |
| FCF Yield | -21.48% | -35.83% | -62.99% | -77.24% | -96.13% | -40.95% | |
| Buyback Yield / Dilution | -114.38% | -114.38% | -105.27% | -133.60% | -19.59% | -105.58% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.